4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000053
CEO bought 51,200 shares at an average $0.01 ($269)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-10-17 | Purchase : show line 1 in the form | +200 | $0.01 | $2 | 25,341,997 | D |
| 2019-10-18 | Purchase : show line 2 in the form | +500 | $0.01 | $4 | 25,342,497 | D |
| 2019-10-18 | Purchase : show line 3 in the form | +500 | $0.01 | $5 | 25,342,997 | D |
| 2019-10-31 | Purchase : show line 4 in the form | +5,000 | $0.00 | $24 | 25,347,997 | D |
| 2019-10-31 | Purchase : show line 5 in the form | +5,000 | $0.00 | $23 | 25,352,997 | D |
| 2019-10-31 | Purchase : show line 6 in the form | +5,000 | $0.00 | $24 | 25,357,997 | D |
| 2019-10-31 | Purchase : show line 7 in the form | +5,000 | $0.00 | $22 | 25,362,997 | D |
| 2019-10-31 | Purchase : show line 8 in the form | +5,000 | $0.00 | $25 | 25,367,997 | D |
| Open-market purchases · 51,200 sh · avg $0.01 · $269 | ||||||
Loading xslF345X03/primary_doc.xml…